PROTOCOL FOR USING ANTIBIOTICS IN THE TREATMENT OF RHEUMATIC DISEASES

from rheumatic.org

E}`̎ÂɍRgpׂ̃vgR[

1996N10Ƀ}T`[ZbcB{XgŊJÂꂽ31č‹ww̔NJoseph M. MercolamɂĔ\ꂽB

-----------------------------------------------------------------------------------------------------
ҒF{ނ̓C^[lbgŌJĂ镶ӔC҂̂ӂŖ|zẑłB
TFDr. Joseph M. Mercola "PROTOCOL FOR USING ANTIBIOTICS IN THE TREATMENT OF RHEUMATIC DISEASES"
URL: http://rheumatic.org/
҂͈ꃊE}`҂ŁAwAp̐Ƃł͖̂ŁA|󕶂ɌAsK؂ȕȂǂL肤̂ŁAsȓ_A_ꍇ́ATQ悤ɂ肢܂B
| ؓY dq[AhXF ohkbr/>-----------------------------------------------------------------------------------------------------

Tv

֐߃E}`͉X̐l̂悻1p[Zge󂯁AȂƂ200l̃AJlmȖ͌ÓTIRAɂĂBRAɂقƂǂ̊҂ɂ́Ais̐g̏QBaɓĂ50%ȏ̊҂RAa5Nɐg̏Q҂ɂĂBč̗N̔ṕA10hȏłƌςB
̎SȂȂB30ˆȏ̊֐߂Ă銳҂5N̐͂悻50%łB͏dĂȊ󓮖aSHodgkinsaƓłB30NO1ľ҂A50ΈȑORAɜ҂͕ςĂPWN̑󂯂ƌ_B

うつ病、不安、精神weelnessのデトックス休暇

قƂǂ̌Ў҂͊͂߂ɋNȂƐMĂBl̐ƒB͗pu𓱓/p>

R̗l̃E}`ɌꂽȂ΁AÖ˂lׂłBʂɁAՏ̍D]ϑ܂ŁAT900mg̗ʂ𓊗^BʂɁA͍ŏ10‚̓^ɋNB̎_ŁAu͐Ö˂sȂȂT͌ǒ`ɒu鎖ɂāAQTԂɂP܂łɌ炷o

ALVV(AMOXICILLIN)

҂ɗzASOHʂȂ΁Aamoxicillin 250mg tidJn邱ƂłB̖K̂ƂASOHʂJԂȂBꂪ܂złȂ΁A‚̃IvVp"\łB4T500mgtidɓ^ʂ𑝉邩A܂Augmentin 250mg tidgp邱ƂłBȂA̖iŔǂ鉺ɊւĊ҂ɌxKvB

iҒFtid PɂR̈Ӂj

̍R

Azulfidineamoxicillin̑֎iƂĂɖ𗧂‚Ȃʂ̖iłBT^Iȓ^ʂ500mg.bid낤BSulfapyridineASÂȂiłAT`_𕞗p̊҂̂߂ɂ͂SȑI낤B

ߋ20NԁA҂RifampinlԂƓ̗҂ɑ΂ĖƉu}̓鎖ĂBɂ́AȂ鑼̍RɂĂLȂp̃j[NȃJjYB1‚̏K͂Ȍ́ARAł̌p𒲍Aꂪ𗧂Ă̂͊mFoȂB

܂A҂́Ảǐ̊֐߉Â̂CeftriaxonegpBȂA͔o̓ł邪ARA̒ȐǗɂĖ邢ʂBCefuroxime axetail̓Ca̎Âɂŋ߁AyjVƃegTCNʓIȂƂāAlׂʂ̍Rł邩ȂBBiaxinZithromax̗lȁA‚̂V}NChnŔAɗzASO HʂŠ҂ɂƂėLȂB

iҒFbid PɂQ̈Ӂj

Rǖ(ANTI-INFLAMMATORIES)

ʏ펄́AsalsalateAT`_igEA}OlVET`_AiȂ킿ASalflex, Disalcid,܂Trilisate)Ȃǂ̗lȔAZ`T`_g悤Ɋ҂ɑE߂ĂBArch Otolaryngol Head Neck Surgery 112:73-76, 1986.

98. Guillon JM, et al: Minocylcine-induced Cell-mediated Hypersensitivity Pneumonitis. Ann Intern Med 117:476-481, 1992.

おむつかぶれのために良いものです

99. Gabriel SE, et al: Rifampin therapy in rheumatoid arthritis. J Rheumatol 17: 163-6, 1990.

100.Caperton EM, et al: Cefiriaxone therapy of chronic inflammatory arthritis. Arch Intern Med 150:1677-1682, 1990. Ann Intern Med 117:273-280, 1992.

101.Clive DM, et al: Renal Syndromes Associated with Nonsteroidal Antiinflammatory drugs. NEngl JMed 310:563-572. March 1 l994.

103.Piper, et al: Corticosteroid Use and Peptic Ulcer Disease: Role of Non-Steroidal Anti-inflammatory Drugs. Ann Intern Med 114:735-740, May 1, 1991.

104.Allison MC, et al: Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs. N Engl J Med 327:749-54, 1992.

105.Fries JF:Postmarketing Drug Surveillance: Are Our Priorities Right? JRheumatol 15:389-390, 1988.

106.Brooks PM, et al: Nonsteroidal Antiinflammatory Drugs Differences and Similarities. NEngl JMed 324:1716-1724, June 13, 1991.

107.Agrawal N: Risk Factors for Gastrointestinal Ulcers Caused by Nonsteroidal Anti-inflammatory Drugs (NSAIDs). J Fam Prac 32:619-624, June 1991.

108.Silverstein, F: Nonsteroidal Anti-Inflammatory Drugs and Peptic Ulcer Disease. Postgrad Med 89:33-30, May 15, 1991.

処方箋なしでにきび薬

109.Gabriel SE, et al: Risk for Serious Gastrointestinal Complications Related to Use of NSAIDs. Ann Intern Med 115:787-796 1991.

110.Fries JF, et al: Toward an Epidemiology of Gastropathy Associated With NSAID Use. Gastroent 96:647-55, 1989.

111.Armstrong CP, et al: NSAIDs and Life Threatening Complications of Peptic Ulceration. Gut 28:527-32, 1987.

112.Murray MD, et al: Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs on Renal Function. AnnInternMed 112:559, April 15, 1990.

113.Cook DM: Safe Use of Glucocorticoids: How to Monitor Patients Taking These Potent Agents. Postgrad Med 91:145-154, Feb. 1992.

114.Piper JM, et al: Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs. Ann Intern Med 114:735-740, May 1, 1991.

115.Thompson JM: Tension Myalgia as a Diagnosis at the Mayo Clinic and Its Relationship to Fibrositis, Fibromyalgia, and Myofascial Pain Syndrome. Mayo Clin Proc 65:1237-1248, September 1990.

116.Semble EL, et al: Therapeutic Exercise for Rheumatoid Arthritis and Osteoarthritis. Seminars in Arthritis and Rheumatism 20:32-40, August 1990.